2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$9.69+$0.13 (+1.41%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.4BMarket Cap
- 11.57%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$9.69+$0.13 (+1.41%)
BCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.55 | ||
Change | -$0.11 (-1.14%) | ||
Open | $9.72 | ||
High | $9.90 | ||
Low | $9.48 | ||
Previous Close | $9.66 | ||
Volume | 2,496,708 | ||
30-Day Average Volume | 3,243,514 | ||
1-Week Change | -1.95% | ||
1-Month Change | 1.38% | ||
1-Year Change | 11.57% | ||
3-Year Change | 27.16% | ||
5-Year Change | -32.79% | ||
Fundamentals | |||
Shares Outstanding | 255.5M | ||
Total Assets | $557.9M | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | $157.5M | ||
Net Income | $78.4M | ||
Free Cash Flow | $104.1M | ||
EBIT | $87.8M | ||
EBITDA | $87.8M | ||
Net Working Capital | $275.8M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | 31 | ||
Enterprise Value/Revenue | 17 | ||
P/B | -5 | ||
P/E | 32 | ||
PEG | 0 | ||
Price/Free Cash Flow | 23 | ||
Price/Operating Cash Flow | 23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue